MOTS-c
FeaturedPowder Peptides
A mitochondrial peptide studied for exercise capacity, metabolic health, and insulin sensitivity.
metabolismendurancefat lossinsulin sensitivity
Learn More← All peptides
Powder Peptides
PEG-Loxenatide
blood sugarinsulin sensitivityweight lossmetabolism
What the research explores
PEG-Loxenatide is a PEGylated exendin-4 analog and GLP-1 receptor agonist approved for treating type 2 diabetes mellitus. It is studied for its effects on blood sugar control and weight management.
In the literature, PEG-Loxenatide appears most often in work focused on blood sugar, insulin sensitivity and weight loss. Studies in this area tend to look at mechanisms and observed effects in laboratory and preclinical settings rather than outcomes in people, so the picture is best read as a map of where researchers have been curious — not as evidence of any benefit.
Because it is catalogued here under powder peptides, PEG-Loxenatide also shows up in discussions of metabolism. Coverage across those topics varies widely in quality and depth, and much of it is early-stage. Reading the underlying research directly is the only way to judge how strong any particular finding is.
Commonly searched for
Tap a topic to see which peptides are most studied for it.
Related peptides
Retatrutide
FeaturedPowder Peptides
A triple-agonist (GLP-1/GIP/glucagon) studied for the strongest weight-loss results in its class.
weight lossappetite controlmetabolism
Learn MoreSemaglutide
FeaturedPowder Peptides
A GLP-1 receptor agonist extensively studied for appetite suppression, weight loss, and glucose control.
weight lossappetite controlblood sugar
Learn MoreResearch use only. This page summarizes areas of published study and is not medical advice. No dosing, protocol, or usage guidance is provided.